ENTITY

Nektar Therapeutics (NKTR US)

Analysis

Health Care • United States

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

Unlimited Research Summaries
Personalised Alerts
Custom Watchlists
Company Analytics & News
Events & Webinars

Trusted by:

Already have an account? Sign In Now